Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02882633 · ClinicalTrials.gov registry record · NA

Lumbar Plexus Block vs Fascia Iliaca Block After Hip Arthroscopy

A NA study of Hip Arthroscopy and Nerve Block, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT02882633 is a NA study of Hip Arthroscopy and Nerve Block that has completed, run by University of Pennsylvania. The registered enrollment target is 50 participants, below the 1,122-participant average among 10 other Hip Arthroscopy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02882633, a NA study of Hip Arthroscopy and Nerve Block, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare lumbar plexus block to fascia iliac block done in adult patients who have undergone hip arthroscopy surgery. Visual analogue scores, opioid consumption, and quality of recovery 48 hours post operatively will be used for comparison.

Interventions

  • DRUG 30ml bolus of bupivacaine

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2015-11
Est. Completion 2018-05
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT02882633

The ClinicalTrials.gov registry entry for NCT02882633 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,122-participant average among 10 other Hip Arthroscopy trials with a reported enrollment target (96% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hip Arthroscopy appearing as the primary indexed condition, and to 1 intervention - of which 30ml bolus of bupivacaine is the first listed.

NCT02882633 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02882633 about?

NCT02882633 is a clinical study titled "Lumbar Plexus Block vs Fascia Iliaca Block After Hip Arthroscopy". The purpose of this study is to compare lumbar plexus block to fascia iliac block done in adult patients who have undergone hip arthroscopy surgery. Visual analogue scores, opioid consumption, and quality of recovery 48 hours post operatively will be used for comparison.

What is the current status of trial NCT02882633?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2015-11. Estimated completion is 2018-05.

What conditions does trial NCT02882633 study?

This clinical trial studies the following conditions: Hip Arthroscopy, Nerve Block.

What interventions are being tested in trial NCT02882633?

The interventions under investigation include: 30ml bolus of bupivacaine (DRUG).

Who is sponsoring clinical trial NCT02882633?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02882633 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hip Arthroscopy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.